Skip to main content
TipRanks
Go Ultimate75% OFF

Stephen Lahue Cartt Insider Profile

4 Followers

Stephen Lahue Cartt, Director at Lineage Therap, holds 292.78K shares in Asterias Biotherapeutics (Ticker: AST), holds 155.13K shares in Lineage Therap (Ticker: LCTX), holds 179.03K shares in Questcor (Ticker: QCOR).

Stephen Lahue Cartt's Trading History

AST
Asterias Biotherapeutics
Apr 03, 2017―Uninformative Buy―$276.68K
LCTX
Lineage Therap
Aug 18, 2015DirectorInformative Buy209.39K$123.32K
QCOR
Questcor
Feb 26, 2014―Uninformative Sell1.70M―

You May Also Like

Stephen Lahue Cartt insider profile FAQ

What is the percentage of profitable transactions made by Stephen Lahue Cartt?
The percentage of profitable transactions made by Stephen Lahue Cartt is 100%.
What is the average return per transaction made by Stephen Lahue Cartt?
The average return per transaction made by Stephen Lahue Cartt is 26.20%.
What stocks does Stephen Lahue Cartt hold?
Stephen Lahue Cartt holds: LCTX, AST, QCOR stocks.
What was Stephen Lahue Cartt's most profitable transaction?
Stephen Lahue Cartt’s most profitable transaction was an Informative Buy of AST stock on July 1, 2016. The return on the trade was 37.50%.
What is Stephen Lahue Cartt's role in Lineage Therap?
Stephen Lahue Cartt's role in Lineage Therap is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.